Abstract
Background: The association between tubo-ovarian abscess formation and the presence of an intrauterine device (IUD) is well recognized. It has been suggested that the risk of upper-genital-tract infection is highest during the immediate period following the insertion of an IUD, returning to baseline by 5 months postinsertion. We present 3 cases of women who, 10–21 years after insertion of their IUDs, developed tubo-ovarian abscesses that were not causally related to sexually transmitted diseases (STDs) or actinomycetes.
Cases: Three women, ages 39–47 years, presented to our gynecology service for evaluation of abdominal pain. One woman had bilateral tubo-ovarian abscesses and the other 2 had unilateral tubo-ovarian abscesses. All 3 were IUD users, with an interval from IUD insertion to presentation of 10–21 years. In each case, the cervical cultures for gonorrhea and chlamydia were negative at presentation and the sexual history was not consistent with an STD mode of spread. All 3 women initially received broad-spectrum antibiotics, but 2 eventually required definitive surgical therapy.
Conclusion: Long-term users of IUDs remain at risk for serious, indolent pelvic infections. These women should be counseled by their gynecologists on an ongoing basis as to this persistent risk. Tubo-ovarian abscess should be strongly considered in the differential diagnosis of an IUD user who presents with an adnexal mass, fever, or abdominal pain.
Full Text
The Full Text of this article is available as a PDF (290.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dawood M. Y., Birnbaum S. J. Unilateral tubo-ovarian abscess and intrauterine contraceptive devices. Obstet Gynecol. 1975 Oct;46(4):429–432. [PubMed] [Google Scholar]
- Duckman S., Suarez J., Tantakesem P. Tuboovarian abscess and the intrauterine device (Majzlin Spring). Am J Obstet Gynecol. 1973 Apr 15;115(8):1157–1158. doi: 10.1016/0002-9378(73)90572-3. [DOI] [PubMed] [Google Scholar]
- Grimes D. A. Intrauterine devices and pelvic inflammatory disease: recent developments. Contraception. 1987 Jul;36(1):97–109. doi: 10.1016/0010-7824(87)90063-1. [DOI] [PubMed] [Google Scholar]
- Kessel E. Pelvic inflammatory disease with intrauterine device use: a reassessment. Fertil Steril. 1989 Jan;51(1):1–11. [PubMed] [Google Scholar]
- Lee N. C., Rubin G. L., Borucki R. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study. Obstet Gynecol. 1988 Jul;72(1):1–6. [PubMed] [Google Scholar]
- Pearlman M., Frantz A. C., Floyd W. S., Faro S. Abdominal wall Actinomyces abscess associated with an intrauterine device. A case report. J Reprod Med. 1991 May;36(5):398–402. [PubMed] [Google Scholar]
- Purdie D. W., Carty M. J., McLeod T. I. Tubo-ovarian actinomycosis and the IUCD. Br Med J. 1977 Nov 26;2(6099):1392–1392. doi: 10.1136/bmj.2.6099.1392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sparks R. A., Purrier B. G., Watt P. J., Elstein M. Bacteriological colonisation of uterine cavity: role of tailed intrauterine contraceptive device. Br Med J (Clin Res Ed) 1981 Apr 11;282(6271):1189–1191. doi: 10.1136/bmj.282.6271.1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor E. S., McMillan J. H., Greer B. E., Droegemueller W., Thompson H. E. The intrauterine device and tubo-ovarian abscess. Am J Obstet Gynecol. 1975 Oct 15;123(4):338–348. doi: 10.1016/s0002-9378(16)33434-2. [DOI] [PubMed] [Google Scholar]